cocaine and Atherosclerotic Parkinsonism

cocaine has been researched along with Atherosclerotic Parkinsonism in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.86)18.7374
1990's17 (48.57)18.2507
2000's15 (42.86)29.6817
2010's1 (2.86)24.3611
2020's1 (2.86)2.80

Authors

AuthorsStudies
Mavri, J; Pregeljc, D; Teodorescu-Perijoc, D; Umek, N; Vianello, R1
Lappin, JM; Sara, GE1
Asenbaum, S; Bencsits, G; Bloem, BR; Brücke, T; Gerschlager, W; Hoffmann, M; Pirker, W; Prayer, D; Zijlmans, JC1
Chung, HK; Jeon, B; Kim, HK; Kim, JM; Kim, JW; Kim, Y; Lee, CR; Lee, DS; Lee, JH; Yang, SO; Yoo, CI1
Kulak, JM; McIntosh, JM; Musachio, JL; Quik, M1
Decristoforo, C; Dierkes, K; Donnemiller, E; Kolbitsch, C; Oberladstätter, M; Poewe, W; Riccabona, G; Scherfler, C; Schocke, M; Wenning, G; Zschiegner, F1
Barthel, H; Collingridge, DR; Hermann, W; Hesse, S; Kluge, R; Sabri, O; Wagner, A1
Brownell, AL; McNaught, KS; Olanow, CW; Perl, DP1
Andringa, G; Bol, JG; Booij, J; de Bruin, K; Drukarch, B; Habraken, JB; Sorman, K1
Faherty, CJ; Lloyd, SA; Smeyne, RJ1
Abbey, R; Alexander, M; Brasic, J; Dannals, RF; Kumar, A; Kuwabara, H; McCann, UD; Palermo, M; Ricaurte, GA; Wong, DF; Ye, W1
al-Tikriti, MS; Elsworth, JD; Innis, RB; Redmond, DE; Roth, RH; Sladek, JR; Taylor, JR1
Brownell, AL; Brownell, GL; Burns, L; Elmaleh, D; Hantraye, P; Pakzaban, P; Petto, AJ; Shoup, T; Spealman, RD; Wüllner, U1
Isacson, O1
Bauer, LO2
Hagiwara, M; Kano, T; Kiuchi, K; Shibuya, M; Suzuki, Y1
Brownell, AL; Brownell, GL; Elmaleh, DR; Fischman, AJ; Madras, BK; Meltzer, PC; Shoup, TM1
Babich, JW; Barrow, SA; Elmaleh, DR; Fischman, AJ; Hanson, RN; Madras, BK; Meltzer, P1
Dhopesh, V; Gamble, G; Maany, I; Macfadden, A1
Booij, J; Tissingh, G; van Royen, EA; Winogrodzka, A; Wolters, EC1
Dhopesh, VP; Weddington, WW; Yagnik, PM1
Bettin, S; Dietrich, J; Kämpfer, I; Knapp, WH; Lössner, J; Reuter, M; Schäfer, A; Seese, A; Wagner, A1
Chang, YS; Jeon, B; Jeong, JM; Kim, JM; Kim, KM; Lee, DS; Lee, MC1
Dannals, RF; McCann, UD; Ricaurte, GA; Villemagne, V; Wong, DF; Yokoi, F1
Brashear, A; Farlow, MR; Hutchins, GD; Mulholland, GK; Siemers, ER; Zheng, QH1
Fujita, M; Ito, Y; Kusuoka, H; Nishimura, T; Okada, T; Shimada, S; Tohyama, M; Watanabe, Y1
Friedman, JH; Goldstein, S; Innis, R; Marek, K; Seibyl, J1
Bohn, MC; Connor, B; Elsworth, JD; Kozlowski, DA; Schallert, T; Tillerson, JL; Unnerstall, JR1
Eising, EG; Müller, T; Peters, S; Przuntek, H1
Kulak, JM; McIntosh, JM; Polonskaya, Y; Quik, M1
Andersson, M; Cenci, MA; Konradi, C1
Snyder, SH1
Brownell, AL; Brownell, GL; Elmaleh, D; Hantraye, P; Isacson, O; Madras, BK; Spealman, RD; Wüllner, U1
Checkoway, H; Franklin, GM; Longstreth, WT; Powers, K; Smith-Weller, T; Swanson, PD1

Reviews

3 review(s) available for cocaine and Atherosclerotic Parkinsonism

ArticleYear
Psychostimulant use and the brain.
    Addiction (Abingdon, England), 2019, Volume: 114, Issue:11

    Topics: Amphetamine; Amphetamine-Related Disorders; Brain; Central Nervous System Stimulants; Cocaine; Cocaine-Related Disorders; Cognitive Dysfunction; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Seizures; Stroke

2019
IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism.
    Journal of neural transmission. Supplementum, 1997, Volume: 50

    Topics: Benzamides; Brain; Cocaine; Diagnosis, Differential; Dopamine; Dopamine Antagonists; Humans; Iodine Radioisotopes; Parkinson Disease; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Risk Factors; Tomography, Emission-Computed, Single-Photon

1997
Vascular Parkinsonism: a case report and review of the literature.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2001, Volume: 8, Issue:3

    Topics: Basal Ganglia Diseases; Cerebral Arteries; Cocaine; Humans; Iodine Radioisotopes; Male; Middle Aged; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2001

Other Studies

32 other study(ies) available for cocaine and Atherosclerotic Parkinsonism

ArticleYear
How Important Is the Use of Cocaine and Amphetamines in the Development of Parkinson Disease? A Computational Study.
    Neurotoxicity research, 2020, Volume: 37, Issue:3

    Topics: Amphetamine; Animals; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Drosophila melanogaster; Humans; Methamphetamine; Models, Neurological; Parkinson Disease, Secondary; Reserpine; Synapses; Vesicular Neurotransmitter Transport Proteins

2020
[123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:3

    Topics: Aged; Aged, 80 and over; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Female; Humans; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2002
Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
    Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:3

    Topics: Causality; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Plasma Membrane Transport Proteins; Humans; Iodine Radioisotopes; Male; Manganese; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Occupational Exposure; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed, Single-Photon

2002
Declines in different beta2* nicotinic receptor populations in monkey striatum after nigrostriatal damage.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 303, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Azetidines; Brain Chemistry; Caudate Nucleus; Cocaine; Conotoxins; Neostriatum; Parkinson Disease, Secondary; Putamen; Radioligand Assay; Receptors, Nicotinic; Saimiri; Substantia Nigra

2002
Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT.
    NeuroImage, 2002, Volume: 17, Issue:1

    Topics: Animals; Cell Count; Cocaine; Dopamine Plasma Membrane Transport Proteins; Magnetic Resonance Imaging; Male; Medial Forebrain Bundle; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Models, Anatomic; Neostriatum; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Radiopharmaceuticals; Rats; Rats, Wistar; Sympatholytics; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tyrosine 3-Monooxygenase

2002
Concordant pre- and postsynaptic deficits of dopaminergic neurotransmission in neurologic Wilson disease.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:2

    Topics: Adult; Benzamides; Brain Mapping; Cerebellum; Cocaine; Corpus Striatum; Dopamine; Female; Hepatolenticular Degeneration; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Male; Middle Aged; Neurologic Examination; Parkinson Disease, Secondary; Psychometrics; Pyrrolidines; Reference Values; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon

2003
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.
    Annals of neurology, 2004, Volume: 56, Issue:1

    Topics: Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Brain; Carbon Radioisotopes; Cocaine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Dopamine Uptake Inhibitors; Hazardous Substances; Humans; Inclusion Bodies; Male; Molecular Structure; Multienzyme Complexes; Oligopeptides; Parkinson Disease, Secondary; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Tomography, Emission-Computed

2004
Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    NeuroImage, 2005, Jul-15, Volume: 26, Issue:4

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon

2005
Adult and in utero exposure to cocaine alters sensitivity to the Parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Neuroscience, 2006, Volume: 137, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Count; Cocaine; DNA Primers; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Immunohistochemistry; Mice; Parkinson Disease, Secondary; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Dopamine D2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2006
Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users.
    Synapse (New York, N.Y.), 2008, Volume: 62, Issue:2

    Topics: Adult; Amphetamine-Related Disorders; Analysis of Variance; Cocaine; Cognition; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Female; Humans; Male; Methamphetamine; Middle Aged; Neuropsychological Tests; Parkinson Disease, Secondary; Positron-Emission Tomography

2008
Novel radioligands for the dopamine transporter demonstrate the presence of intrastriatal nigral grafts in the MPTP-treated monkey: correlation with improved behavioral function.
    Experimental neurology, 1994, Volume: 126, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Chlorocebus aethiops; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Fetal Tissue Transplantation; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Parkinson Disease, Secondary; Radioligand Assay; Serotonin Plasma Membrane Transport Proteins; Substantia Nigra; Transplantation, Heterotopic; Transplantation, Homologous

1994
Dopamine terminal loss and onset of motor symptoms in MPTP-treated monkeys: a positron emission tomography study with 11C-CFT.
    Experimental neurology, 1994, Volume: 126, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Carbon Radioisotopes; Caudate Nucleus; Cocaine; Dopamine; Motor Activity; Nerve Endings; Parkinson Disease, Secondary; Putamen; Tomography, Emission-Computed

1994
Clinical and preclinical PET correlates of parkinsonism with 11C-WIN 35,428.
    Annals of neurology, 1994, Volume: 35, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carbon Radioisotopes; Cocaine; Humans; Parkinson Disease; Parkinson Disease, Secondary; Tomography, Emission-Computed

1994
Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal.
    Psychiatry research, 1993, Volume: 47, Issue:1

    Topics: Adult; Alcohol Withdrawal Delirium; Alcoholism; Cerebellar Ataxia; Cocaine; Female; Humans; Male; Neurologic Examination; Parkinson Disease, Secondary; Postural Balance; Substance Withdrawal Syndrome; Substance-Related Disorders; Tremor

1993
Cocaine-induced CREB phosphorylation and c-Fos expression are suppressed in Parkinsonism model mice.
    Neuroreport, 1995, Nov-13, Volume: 6, Issue:16

    Topics: Animals; Cocaine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Dopamine Uptake Inhibitors; Mice; Mice, Inbred C3H; Nerve Tissue Proteins; Parkinson Disease, Secondary; Phosphorylation; Proto-Oncogene Proteins c-fos; Rabbits

1995
Resting hand tremor in abstinent cocaine-dependent, alcohol-dependent, and polydrug-dependent patients.
    Alcoholism, clinical and experimental research, 1996, Volume: 20, Issue:7

    Topics: Alcoholism; Basal Ganglia; Cocaine; Down-Regulation; Female; Humans; Male; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Tremor

1996
Cocaine congeners as PET imaging probes for dopamine terminals.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Carbon Radioisotopes; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Female; Macaca fascicularis; Male; Nerve Endings; Parkinson Disease, Secondary; Tomography, Emission-Computed

1996
SPECT imaging of dopamine transporter sites in normal and MPTP-Treated rhesus monkeys.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding Sites; Carrier Proteins; Cocaine; Contrast Media; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Iodine Radioisotopes; Macaca mulatta; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Nortropanes; Parkinson Disease; Parkinson Disease, Secondary; Tissue Distribution; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon

1997
Absence of parkinsonism among patients in long-term neuroleptic therapy who abuse cocaine.
    Psychiatric services (Washington, D.C.), 1997, Volume: 48, Issue:1

    Topics: Adult; Antipsychotic Agents; Chronic Disease; Cocaine; Comorbidity; Delayed-Action Preparations; Fluphenazine; Haloperidol; Humans; Long-Term Care; Male; Middle Aged; Neurologic Examination; Opioid-Related Disorders; Parkinson Disease, Secondary; Receptors, Dopamine; Risk Factors; Schizophrenia

1997
Can cocaine abuse cause parkinsonism?
    The American journal on addictions, 1997,Spring, Volume: 6, Issue:2

    Topics: Adult; Brain Chemistry; Cocaine; Dopamine; Humans; Male; Matched-Pair Analysis; Middle Aged; Narcotics; Parkinson Disease, Secondary; Substance-Related Disorders

1997
[Striatal uptake of I-123-beta-CIT and I-123-IBZM in patients with extrapyramidal symptoms].
    Nuklearmedizin. Nuclear medicine, 1997, Volume: 36, Issue:5

    Topics: Adult; Aged; Basal Ganglia; Benzamides; Carrier Proteins; Cerebellum; Cocaine; Corpus Striatum; Dopamine Plasma Membrane Transport Proteins; Female; Frontal Lobe; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease, Secondary; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed

1997
Dopamine transporter imaging with [123I]-beta-CIT demonstrates presynaptic nigrostriatal dopaminergic damage in Wilson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1998, Volume: 65, Issue:1

    Topics: Adolescent; Adult; Brain Mapping; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dystonia; Female; Hepatolenticular Degeneration; Humans; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Neurologic Examination; Occipital Lobe; Parkinson Disease, Secondary; Substantia Nigra; Tomography, Emission-Computed, Single-Photon

1998
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20

    Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Central Nervous System Stimulants; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Middle Aged; Neostriatum; Nerve Tissue Proteins; Parkinson Disease, Secondary; Propiophenones; Tomography, Emission-Computed

1998
PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP).
    Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1

    Topics: Adult; Aged; Brain Mapping; Carbon Radioisotopes; Cocaine; Corpus Striatum; Diagnosis, Differential; Dopamine; Dopamine Uptake Inhibitors; Dystonia; Female; Homovanillic Acid; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Pilot Projects; Receptors, Dopamine; Receptors, Presynaptic; Tomography, Emission-Computed

1999
Comparison between the decrease of dopamine transporter and that of L-DOPA uptake for detection of early to advanced stage of Parkinson's disease in animal models.
    Synapse (New York, N.Y.), 1999, Mar-01, Volume: 31, Issue:3

    Topics: Animals; Biological Transport; Brain; Carrier Proteins; Cocaine; Disease Models, Animal; Dopa Decarboxylase; Dopamine Plasma Membrane Transport Proteins; Female; Gene Expression Regulation; Levodopa; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Neuropeptides; Parkinson Disease, Secondary; Radioligand Assay; Rats; Rats, Wistar; Rotation; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins

1999
Hemi-parkinsonism due to a midbrain arteriovenous malformation: dopamine transporter imaging.
    Movement disorders : official journal of the Movement Disorder Society, 2001, Volume: 16, Issue:2

    Topics: Adult; Biological Transport; Carrier Proteins; Caudate Nucleus; Cocaine; Corpus Striatum; Dopamine; Female; Humans; Intracranial Arteriovenous Malformations; Magnetic Resonance Imaging; Mesencephalon; Parkinson Disease, Secondary; Putamen; Radiopharmaceuticals; Substantia Nigra; Tomography, Emission-Computed, Single-Photon

2001
Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Experimental neurology, 2001, Volume: 169, Issue:1

    Topics: Aging; Animals; Autoradiography; Carrier Proteins; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Male; Membrane Glycoproteins; Membrane Transport Proteins; Microinjections; Motor Activity; Nerve Growth Factors; Nerve Tissue Proteins; Neurons; Neurotransmitter Agents; Oxidopamine; Parkinson Disease, Secondary; Presynaptic Terminals; Rats; Rats, Inbred F344; RNA, Messenger; Substantia Nigra; Tyrosine 3-Monooxygenase

2001
Vulnerability of 125I-alpha-conotoxin MII binding sites to nigrostriatal damage in monkey.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001, Aug-01, Volume: 21, Issue:15

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Binding Sites; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Carrier Proteins; Cocaine; Conotoxins; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Habenula; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Nerve Tissue Proteins; Neural Pathways; Neurons; Parkinson Disease, Secondary; Putamen; Pyridines; Receptors, Nicotinic; Saimiri; Substantia Nigra

2001
cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2001, Dec-15, Volume: 21, Issue:24

    Topics: Animals; Antiparkinson Agents; Cocaine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; Denervation; DNA; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Routes; Enkephalins; Female; Gene Expression; Levodopa; Oligonucleotides, Antisense; Oxidopamine; Parkinson Disease, Secondary; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transcription Factor AP-1

2001
Biochemical factors in Schizophrenia.
    Hospital practice, 1977, Volume: 12, Issue:10

    Topics: Amphetamines; Animals; Binding Sites; Brain; Cocaine; Dopamine; Humans; Levodopa; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Receptors, Dopamine; Schizophrenia; Tranquilizing Agents

1977
Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.
    Neuroreport, 1992, Volume: 3, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cocaine; Disease Models, Animal; Dopamine; Immunohistochemistry; Macaca fascicularis; Motor Activity; Nerve Fibers; Parkinson Disease, Secondary; Radioligand Assay; Tomography, Emission-Computed

1992
Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake.
    American journal of epidemiology, 2002, Apr-15, Volume: 155, Issue:8

    Topics: Adult; Aged; Alcohol Drinking; Caffeine; Case-Control Studies; Coffee; Cola; Female; Humans; Male; Middle Aged; Odds Ratio; Parkinson Disease; Parkinson Disease, Secondary; Phosphodiesterase Inhibitors; Population Surveillance; Risk Assessment; Risk Factors; Smoking; Tea; Washington

2002